Improving Diabetic Neuropathy Symptoms with Dendritic Cells
Author Information
Author(s): Setiawan Erwin, Ginting Chrismis Novalinda, Jonny Jonny, Hernowo Bhimo Aji, Putranto Terawan Agus
Primary Institution: Gatot Soebroto Central Army Hospital
Hypothesis
Does autologous dendritic cell administration improve symptoms of diabetic neuropathy?
Conclusion
The study found that autologous dendritic cell administration significantly improved diabetic neuropathy symptoms.
Supporting Evidence
- Patients showed a significant reduction in the Toronto Clinical Neuropathy Score after treatment.
- TGF-β levels increased slightly, indicating a potential anti-inflammatory effect.
- Correlation analysis revealed significant relationships between TGF-β and neuropathy symptoms.
Takeaway
Doctors gave special cells from patients' own immune systems to help with nerve pain from diabetes, and it worked well.
Methodology
A quasi-experimental clinical trial was conducted with 28 diabetic neuropathy patients receiving autologous dendritic cell injections, measuring symptoms and biomarkers before and after treatment.
Potential Biases
Conducted at a single center, which may limit generalizability.
Limitations
The study had a small sample size and short follow-up period, and lacked a randomized control group.
Participant Demographics
Average age of participants was 61 years, with 32% men and 68% women; most had hypertension.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website